World Healthcare Report
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on World Healthcare Report.

ALYKA Health now a Supporting Partner of the American Society of Preventive Cardiology

ALYKA Health now a Supporting Partner of the American Society of Preventive Cardiology

Empowering Patients to Close Preventable Cardiovascular Care Gaps and Improve Health Outcomes ATLANTA, GA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- ALYKA Health, a digital health company that partners with providers to empower patients...

Fabry Disease Market Analysis 2025 – Insights For Long-Term Investment & Planning

Fabry Disease Market Analysis 2025 – Insights For Long-Term Investment & Planning

The Business Research Company's Fabry Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest...

cormeo and IPHA Join Forces in Mutual Stewardship of medicines.ie

cormeo and IPHA Join Forces in Mutual Stewardship of medicines.ie

Setting new Standards in Medicinal Information Distribution throughout Europe GüTERSLOH, GERMANY, June 16, 2025 /⁨EINPresswire.com⁩/ -- cormeo, the newly established Pharma Tech holding company under Bertelsmann Investments, announces its Venture...

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has...

Call My Doctor Expands 24/7 Doctor On Call Services with DHA-Certified Medical Care Across Dubai

Call My Doctor Expands 24/7 Doctor On Call Services with DHA-Certified Medical Care Across Dubai

Get fast, professional medical care with DHA-certified doctors on call across Dubai. Home, hotel, or office visits available 24/7. Book now! DUBAI, DUBAI, UNITED ARAB EMIRATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- Call My Doctor, a leading...

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amid Growing Mental Health Crisis

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amid Growing Mental Health Crisis

Falmouth addiction treatment facility adds a dedicated mental health program to ease the mental health crisis. FALMOUTH, MA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- The Recovery Team - Cape Cod is expanding its addiction treatment...

Galen Growth Redefines Digital Health Intelligence with AI-Powered Analytics Platform

Galen Growth Redefines Digital Health Intelligence with AI-Powered Analytics Platform

With unmatched data precision and AI-powered analytics, Galen Growth emerges as the category leader in global digital health intelligence. BASEL, BASEL-STADT, SWITZERLAND, June 16, 2025 /⁨EINPresswire.com⁩/ -- Galen Growth today unveiled Alpha...

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)

XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International Recognition Procedure AVEROA actively seeking strategic...

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amidst Growing Mental Health Crisis - DELETED

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amidst Growing Mental Health Crisis - DELETED

Falmouth addiction treatment facility adds a dedicated mental health program to ease the mental health crisis. FALMOUTH, MA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- FALMOUTH, Mass. — [May 16, 2025] — The Recovery Team - Cape Cod is...

Scipher Medicine expands its global presence, bringing precision medicine to Latin America through an alliance with Grupo Amarey

Scipher Medicine expands its global presence, bringing precision medicine to Latin America through an alliance with Grupo Amarey

Scipher Medicine, a leading precision immunology company, today announced a strategic alliance with Grupo Amarey, a leading company in the representation and distribution of technologies, solutions, and services for the healthcare sector in...

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated...

D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions in Liver Fat Accompanied by Improvements in Liver and Metabolic Health

D&D Pharmatech Announces Positive Phase 2 Results for DD01 in MASH with Robust Reductions in Liver Fat Accompanied by Improvements in Liver and Metabolic Health

D&D Pharmatech, Inc. (D&D) (KOSDAQ: 347850), a clinical-stage biotechnology company developing breakthrough treatments for liver and metabolic diseases, today announced positive results from DD01-DN-02 study, an ongoing 48-week Phase 2 trial...

ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients

ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced initiation of patient enrollment for a landmark clinical study utilizing its Avantect® Pancreatic Cancer Test. Sponsored by...

Korea Smart Healthcare Association and SL Foundation Sign MOU for Development of Multimodal, AI, and Blockchain-Based Medical Platform

Korea Smart Healthcare Association and SL Foundation Sign MOU for Development of Multimodal, AI, and Blockchain-Based Medical Platform

Singapore, June 16, 2025 (GLOBE NEWSWIRE) -- On June 10, 2025, the Korea Smart Healthcare Association (Chairman: Ki-Jun Shim) and SL Foundation (CEO: Sang-Sub Gong) signed a Memorandum of Understanding (MOU) to form a strategic partnership aimed...

Tend Health Appoints Dr. Namit Choksi as CEO to Lead Strategic Growth and Deepen Commitment to Clinician-Centered Mental Health Care

Tend Health Appoints Dr. Namit Choksi as CEO to Lead Strategic Growth and Deepen Commitment to Clinician-Centered Mental Health Care

Tend Health, a specialized, concierge-level telepsychology and telepsychiatry services provider exclusively designed for healthcare professionals, has announced the appointment of Dr. Namit Choksi as its new Chief Executive Officer (CEO). This...

ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 11 Court Deadline (NYSE:ELV)

ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 11 Court Deadline (NYSE:ELV)

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential...

Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™

Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™

Veristat, a leading global clinical research organization (CRO) and consultancy, proudly congratulates George Medicines on the U.S. Food and Drug Administration (FDA) approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a novel single...

Bennett Blau Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

Bennett Blau Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group

Evercore (NYSE: EVR) announced today that Bennett Blau has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the medical technology sector. He will be based in San Francisco. Naveen...

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"

OMER, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the receipt of an initial order for...

RUCKUS Networks Announces Next-Generation AI and Wi-Fi 7 Solutions for Every Tier Within the Hospitality Industry

RUCKUS Networks Announces Next-Generation AI and Wi-Fi 7 Solutions for Every Tier Within the Hospitality Industry

CommScope (NASDAQ: COMM), a global leader in network connectivity, today announced new AI-driven Wi-Fi 7 and Gen AI-based solutions from RUCKUS Networks, which round out its portfolio for the hospitality industry. The portfolio of solutions...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service